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 20 
Review title 21 
Footwear and insole design features to prevent foot ulceration in adults with diabetes: A systematic 22 
review protocol 23 
Review question/objective 24 
The aim of this systematic review is to identify the key design features of footwear and insoles which 25 
are used to offload the plantar surface of the foot to prevent foot ulceration in adults with diabetes.  26 
More specifically, the objectives are to identify the key design features of footwear and insoles to 27 
offload the plantar surface of the foot with regard to: 28 
 profile/shape of the insole, shoe upper and shoe outsole 29 
 material type and properties of the insole and shoe outsole 30 
 modifications made to the insole and shoe outsole 31 
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 fabrication techniques used for the insole and shoe 32 
Background 33 
Diabetes is a disease with devastating multi-factorial complications which causes an economic 34 
burden to healthcare providers.
1
 The global prevalence of diabetes was reported at 336 million people 35 
in 2011 and is expected to rise to 552 million by 2030.2 In the United Kingdom (UK) around 1.2 million 36 
adults (5.7% of the adult population) are diagnosed with diabetes. This figure is anticipated to grow by 37 
a further 1.4% over the next 15 years.
3 
 It is expected that 25% of people with diabetes will develop a 38 
foot ulcer at some point.4 Foot ulceration is a limb and life threatening condition known to precede 39 
80% of all diabetic lower limb amputations.
5 40 
Diabetic foot amputation is associated with poor quality of life and high rates of mortality.6   Following 41 
primary foot amputation, the five-year mortality rate is in the region of 44%.1   Estimates of the 42 
National Health Services (NHS) annual expenditure for the treatment of the diabetic ulcerated foot 43 
were approximately £591 million,1 whilst indirect costs associated with loss of productivity, sickness 44 
and informal care in the UK were estimated at £14 billion for 2010-2011.7  45 
 46 
Approximately 30% of people with diabetes will develop peripheral neuropathy.4  Diabetic peripheral 47 
neuropathy (DPN) is a risk factor for the development of foot ulceration.  There are three types of 48 
DPN: sensory, motor and autonomic. Sensory neuropathy is a loss of the body’s protective feedback 49 
mechanism in response to pain or touch.8   Motor neuropathy can cause changes in joint mobility and 50 
strength, foot structure/deformity and plantar foot pressures9-12 whilst autonomic neuropathy 51 
contributes to plantar tissue quality loss.13-15  Areas at increased susceptibility of ulceration are often in 52 
the forefoot region, where the combination of loss of protective sensory feedback, tissue ischemia and 53 
elevated plantar pressure loading can result in ulceration.16   54 
 55 
Elevated dynamic plantar pressures during locomotion are known to contribute to the development of 56 
diabetic foot ulcers when in the presence of neuropathy.
17 
  Reducing high plantar loads or foot 57 
pressures is therefore one mechanism by which foot ulceration maybe prevented.18-19   58 
Recommendations for the prevention of diabetic foot ulcer are multidisciplinary and holistic in their 59 
approach. However, offloading footwear and insoles has been recognized as one important element 60 
of the foot ulcer prevention strategy. 61 
 62 
 63 
An initial search of the literature published prior to September 2016 was completed using the following 64 
databases: AMED, EMBASE, MEDLINE, BNI, CINAHL, the Cochrane Database of Systematic 65 
Reviews and PROSPERO databases, and the Joanna Briggs Institute Database of Systematic 66 
Reviews and Implementation Reports. This initial literature search suggests that there is a general 67 
consensus that footwear and insoles are effective in reducing the load under the foot and preventing 68 
ulceration .20-23,26   However an evaluation of the specific design features and modes of action that 69 
function to alter the load under the foot has not been comprehensively reported. Paton et al (2011) 70 
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focused on the effectiveness of insoles used in Randomized Controlled Trial’s (RCT’s) before 2008 71 
but did not include the specification or design of the insoles used within the comparative studies.21  72 
The reviews by Bus et al (2015) and van Netten et al (2016) presented a more comprehensive 73 
analysis of factors for preventing foot ulceration and re-ulceration in the at-risk patient with 74 
diabetes.22,23  Their findings highlighted only one study which emphasised the design features of 75 
footwear and insoles using a prescription algorithm
24
 and one study that used in-shoe pressure 76 
measurements to inform the footwear.
25
 Heuch and Gomersall’s (2016) systematic review identified 77 
three studies of poor quality evidence to support methods of offloading for preventing primary diabetic 78 
foot ulceration only.  Whilst the components of the insole and footwear used to offload were presented 79 
from the studies, the key design features and mode of action were not identified, as was the lack of 80 
exploration of offloading on those with a past history of ulceration.26   81 
 82 
None of the reviews to date have included robust studies which investigate the effectiveness of 83 
particular design features for insole and footwear manufacture. Without this important clinically 84 
relevant information, those tasked with providing insoles for people with diabetes are unable to 85 
determine which insole and footwear type or design is best for preventing foot ulceration. This should 86 
be related to the design features of the footwear or insole, and should include details associated with 87 
the profile/shape, material properties, integrated modifications and fabrication.27,28  A scoping of the 88 
existing literature, using identical databases as in the initial search, reveals a large variety of design 89 
features for insoles and footwear that merits further exploration. 90 
 91 
Therefore the purpose of this systematic literature review is to bridge the existing gap in the literature 92 
and identify the key design features of footwear and insoles used to offload the plantar surface of the 93 
foot to prevent foot ulceration in people with diabetes.  It is anticipated that this information will inform 94 
a protocol for the clinical design of therapeutic insoles and footwear within a RCT to offload the foot 95 
and reduce ulcer risk in people with diabetes and neuropathy.  96 
 97 
Inclusion and exclusion criteria 98 
Types of participants 99 
This review will consider studies that include adults over 18 years with type 1 or type 2 diabetes, 100 
regardless of duration of diabetes,  history of previous foot ulceration or other co-morbidities, without 101 
any amputation or Charcot arthropathy. It will exclude studies of people with current foot ulceration on 102 
entry to the study.  103 
Types of intervention(s) 104 
Studies will be considered that evaluate the effectiveness of any footwear and/or insole design 105 
features intended to offload the plantar surface of the diabetic foot for ulcer prevention. 106 
Studies will be included if they make one of the following comparisons: 107 
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1. Footwear and/or insole design feature compared to another therapeutic footwear and/or 108 
insole design feature 109 
2. Footwear and/or insole design feature compared to no intervention   110 
Footwear and/or insole design features will be defined as any identifiable and distinguishing 111 
characteristic integral to the footwear or insole device. These may include, but are not limited to: 112 
footwear outsole profile variations (heel height, rocker modifications), footwear upper style variations 113 
(boots, shoes, sandals), insoles/orthoses profile variations (with/without arch support, metatarsal bars, 114 
1
st
 ray cut-outs, kinetic wedges, internal and external posting), differences in insole/orthosis material 115 
properties (rigid or soft devices), shaped padding applied to the foot (plantar covers, ring pads), and 116 
variations in the design and stiffness of ankle foot orthosis used to restrict ankle joint dorsiflexion 117 
(rigid/semi-rigid). Excluded will be studies that investigate offloading devices intended for the 118 
treatment of foot ulceration as the indications and rationale for use are not consistent with the 119 
objectives of this systematic review. 120 
 121 
Types of outcomes 122 
This review will consider studies that include either of the following 123 
 primary outcome measures of foot ulceration incidence or frequency 124 
 and/or secondary outcome measures of:  125 
 Any standardized kinetic or kinematic outcome measure indicating loading or offloading the 126 
plantar foot: such as plantar pressure (eg reduction  in mean peak pressure, reduction in 127 
pressure time integral, increase in total contact area, and changes in the dynamic measures 128 
of centre of pressure trajectory or velocity). 129 
 Any standardized clinical measure indicating loading/offloading of the plantar foot: such as 130 
callus/lesion reduction.  131 
 Any side effects/adverse events as a result of the design features 132 
 133 
Types of studies 134 
This review will consider both experimental and epidemiological study designs including randomized 135 
controlled trials, non-randomized controlled trials, quasi-experimental, before and after case series 136 
studies, prospective and retrospective cohort studies and analytical cross sectional studies for 137 
inclusion.   138 
This review will exclude qualitative studies, case reports and systematic reviews.  139 
 140 
Search strategy 141 
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The search strategy aims to find both published and unpublished studies. A three-step search 142 
strategy will be utilized. An initial limited search of MEDLINE and CINAHL will be undertaken followed 143 
by analysis of the text words contained in the title and abstract, and of the index terms used to 144 
describe the article. A second search using all identified keywords and index terms will then be 145 
undertaken across all included databases. Thirdly, the reference list of all identified reports and 146 
articles will be searched for additional studies. A research librarian will assist in designing search 147 
terms for various databases. Studies published in English will be considered for inclusion in this 148 
review. Studies published from inception to present will be considered for inclusion in this review. 149 
 150 
The databases to be searched include: 151 
AMED (EBSCO), CINAHL, MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials. 152 
Joanna Briggs Institute Database of Systematic Reviews, and PROSPERO will be will be used to 153 
check the reference list of relevant systematic reviews to ensure all appropriate papers are included in 154 
the search. 155 
The search for unpublished studies and gray literature will include: 156 
EThOS, Pearl, Web of Science, Google Scholar, SIGLE 157 
 158 
Initial keywords and MeSH terms to be used will be: 159 
1. diabet* 160 
2. diabetes mellitus [MeSH] 161 
3. foot feet 162 
4. neuropath* 163 
5. ulcer* 164 
6. pressure [MeSH] 165 
7. gait  166 
8. walking  167 
9. time 168 
10. offload* 169 
11. off-load* 170 
12. insole* 171 
13. orthos* 172 
14. orthotic devices [MeSH] 173 
15. therapeutic footwear 174 
16. shoes[MeSH] 175 
17. footwear 176 
18. rocker  177 
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 178 
Assessment of methodological quality 179 
Two independent reviewers (RC / JP) will assess papers selected for retrieval. The reviewers will 180 
initially scan the titles and abstracts to exclude papers that do not align with the inclusion criteria. Full 181 
text articles will be obtained for papers that meet the inclusion criteria or where uncertainty exists. The 182 
full text articles will then be read and those that fulfil the inclusion criteria will be assessed for 183 
methodological validity prior to inclusion in the review.  Papers selected for retrieval will be assessed 184 
using standardized critical appraisal instruments from the Joanna Briggs Institute System for the 185 
Unified Management, Assessment and Review of Information (JBI SUMARI) (Appendix I). Any 186 
disagreements that arise between the reviewers will be resolved through discussion, or with two other 187 
reviewers (JF / JML). 188 
 189 
Data extraction 190 
The data will be extracted by two independent reviewers.  Data will be extracted from papers included 191 
in the review using the standardized data extraction tool from JBI SUMARI (Appendix III). The data 192 
extracted will include specific details about the footwear and/or insole design features, populations, 193 
study methods and outcomes of significance to the review question and specific objectives.  If there is 194 
information missing in relevant studies, the corresponding author will be contacted and given the 195 
opportunity to clarify the information.   196 
Data synthesis 197 
Quantitative data will, where possible be pooled in statistical meta-analysis using JBI SUMARI. All 198 
results will be subject to double data entry. Effect sizes expressed as odds ratio (for categorical data) 199 
and weighted mean differences (for continuous data) and their 95% confidence intervals will be 200 
calculated for analysis. Heterogeneity will be assessed statistically using the standard Chi-square and 201 
also explored using subgroup analyses based on the different study designs included in this review. 202 
Where statistical pooling is not possible the findings will be presented in narrative form including 203 
tables and figures to aid in data presentation where appropriate. 204 
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Appendix I: Appraisal instruments 317 
SUMARI Appraisal instrument 318 
this is a test message 319 
 320 
Insert page break 321 
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Insert p324 
325 
age  326 
 327 
 328 
 329 
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Reviewer      Date      331 
 332 
Author       Year  Record Number        333 
 334 
 Yes No Unclear Not 
applicable 
1. Were the criteria for inclusion in the sample 
clearly defined? □ □ □ □ 
2. Were the study subjects and the setting described 
in detail? □ □ □ □ 
3. Was the exposure measured in a valid and reliable 
way? □ □ □ □ 
4. Were objective, standard criteria used for 
measurement of the condition? □ □ □ □ 
5. Were confounding factors identified? □ □ □ □ 
6. Were strategies to deal with confounding factors 
stated? □ □ □ □ 
7. Were the outcomes measured in a valid and 
reliable way? □ □ □ □ 
8. Was appropriate statistical analysis used? □ □ □ □ 
Overall appraisal:  Include   □ Exclude   □ Seek further info  □ 335 
Comments (Including reason for exclusion) 336 
             337 
             338 
             339 
340 
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break 341 
 342 
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Appendix II: SUMARI Data extraction instruments 344 
 345 
 346 
 347 
